Enamel Matrix Derivatives & Periodontal Therapy in Diabetic Patients (PERIOEMD-4)

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    38
  • sponsor
    University of Pisa
Updated on 24 February 2022
diabetes
type 2 diabetes mellitus
periodontitis
periodontal treatment

Summary

The aim of this study is to compare periodontal treatment with or without the adjunct of an enamel matrix derivative in terms of periodontal healing in diabetic patients.

Description

Patients with periodontitis will be randomly allocated to two groups. In both groups, periodontal root instrumentation will be performed. In the test group, an additional flapless application of enamel matrix derivatives will be granted for sites with pockets deeper than 5 mm.

Metabolic glucose control as measured through blood testing and local parameters of periodontal health will be measured at baseline and three months after treatment completion.

Details
Condition Periodontal Diseases
Treatment Root Instrumentation, Enamel Matrix Derivative application
Clinical Study IdentifierNCT04237662
SponsorUniversity of Pisa
Last Modified on24 February 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients diagnosed with diabetes mellitus type II and currently under treatment
No previous periodontal treatment in the last 6 months
Presence of Periodontitis (Clinical attachment loss of at least 3 mm in 2 or more nonadjacent teeth)
Ability to understand the study procedures and comply with them through the length of the study

Exclusion Criteria

Pregnancy and breast feeding
Need for antibiotic treatment during periodontal therapy
Chronic infections
Systemic diseases
Patients who report current smoking over 20 cigarettes per day
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note